SCANDINAVIAN CHEMOTECH AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.24 SEK | -1.32% |
|
0.00% | -17.04% |
Presenter SpeechRobin Sukhia (Executives)[Audio Gap]
researchers ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Scandinavian ChemoTech AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused on cancer treatment and manufactures specialized medical equipment. The Company's product IQWave is an electrochemotherapy (ECT) device. The IQWave system enhances the effects of the chemotherapeutic substance by opening up small pores in the tumor cells, giving the injected chemotherapeutic substance (no more than 15 IU of bleomycin) direct access to the DNA of the target cells. Among the product's applications are hypernephroma, kaposi sarcoma, transitional cell carcinoma, head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma. The treatment can be used for cutaneous as well as subcutaneous tumors.
Calendar
2024-05-13
- Q1 2024 Earnings Release
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.04% | 3.66M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- CMOTEC B Stock
- News Scandinavian ChemoTech AB
- Transcript : Scandinavian ChemoTech AB - Special Call
